Agenus Inc. - Common Stock (NQ:AGEN)

6.670 -0.280 (-4.03%)

Delayed Quote Updated: 2:24 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Agenus Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Recap: Agenus Q2 Earnings ↗

August 09, 2021

Shares of Agenus (NASDAQ:AGEN) moved higher by 2.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 32.14% over...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Why Agenus Stock Sank on Tuesday ↗

July 27, 2021

A top company executive is stepping down in the very near future.

Via The Motley Fool

50 Biggest Movers From Yesterday ↗

June 18, 2021

Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share. Midatech Pharma plc (NASDAQ...

Via Benzinga

Topics Initial Public Offering

What's Going On With Agenus Stock Today? ↗

May 18, 2021

Agenus Inc (NASDAQ:AGEN) shares are trading higher by 35.2...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Why Agenus Stock Is Marching Higher Today ↗

June 17, 2021

The biotech took a major step toward becoming a commercial-stage cancer company.

Via The Motley Fool

34 Stocks Moving In Thursday's Mid-Day Session ↗

June 17, 2021

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 68.5% to $5.51 after the company announced it filed a registration statement in connect with the proposed merger...

Via Benzinga

Agenus Gains As Balstilimab US Application Accepted For Review In Cervical Cancer ↗

June 17, 2021

The FDA has accepted for review Agenus Inc's (NASDAQ: AGEN) marketing application seeking approval for balstilimab for recurrent or metastatic cervical cancer...

Via Benzinga

8 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

June 11, 2021

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away...

Via Benzinga

75 Biggest Movers From Yesterday ↗

June 09, 2021

Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail investor interest in the stock. NextDecade...

Via Benzinga

Why Agenus Stock Is Jumping Today ↗

June 08, 2021

There was some positive news, but it probably wasn't a huge catalyst for the stock.

Via The Motley Fool

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗

May 31, 2021

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...

Via Benzinga

4 Biotech Stocks Wall Street Analysts Predict Will Gain More Than 60% ↗

May 22, 2021

The integration of technology and successful clinical trials for treating critical ailments have boosted Wall Street’s optimism about several biotech stocks. Analysts expect Bionano, Cerus, Agenus and...

Via Talk Markets

Why ‘Killer’ T Cells Could Boost COVID Immunity In Face Of New Variants

May 20, 2021

Via FinancialNewsMedia

2 Grossly Undervalued Biotech Stocks That Could Double Your Money ↗

May 19, 2021

Aurinia Pharmaceuticals and Agenus might be poised for a healthy growth spurt.

Via The Motley Fool

Why Agenus Stock Skyrocketed Today ↗

May 18, 2021

The biotech announced a big licensing deal with Bristol Myers Squibb.

Via The Motley Fool

58 Biggest Movers From Yesterday ↗

May 19, 2021

Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results. Ultralife Corporation (NASDAQ: ULBI)...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Turns Negative; Ultralife Shares Spike Higher ↗

May 18, 2021

Toward the end of trading Tuesday, the Dow traded down 0.39% to 34,192.78 while the NASDAQ fell 0.11% to 13,364.14. The S&P also fell, dropping 0.42% to 4,145.60. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 18, 2021

Gainers Onconova Therapeutics (NASDAQ:ONTX) shares moved upwards by 41.84% to $0.88 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

Mid-Day Market Update: TOMI Environmental Solutions Falls After Q1 Results; Agenus Shares Jump ↗

May 18, 2021

Midway through trading Tuesday, the Dow traded down 0.16% to 34,272.59 while the NASDAQ rose 0.69% to 13,470.97. The S&P also rose, gaining 0.03% to 4,164.63. The U.S. has the...

Via Benzinga

Topics Stocks

42 Stocks Moving In Tuesday's Mid-Day Session ↗

May 18, 2021

Gainers Agenus Inc. (NASDAQ: AGEN) shares surged 33.4% to $4.35. Bristol-Myers Squibb Co and Agenus entered into a global exclusive license agreement, under which Bristol Myers...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Walmart Tops Q1 Expectations ↗

May 18, 2021

Following the market opening Tuesday, the Dow traded down 0.23% to 34,248.63 while the NASDAQ rose 0.39% to 13,431.72. The S&P also fell, dropping 0.13% to 4,158.02. The U.S....

Via Benzinga

Topics Stocks

Bristol Myers Inks $1.6B Licensing Agreement For Agenus' Bispecific Antibody Program In Solid Tumors ↗

May 18, 2021

Bristol-Myers Squibb Co (NYSE: BMY) and Agenus Inc (NASDAQ: AGEN) have entered into a global exclusive license agreement, under which Bristol Myers will...

Via Benzinga

Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program

May 18, 2021

From Bristol-Myers Squibb

Via Business Wire

Why Agenus Stock Tumbled Today ↗

May 06, 2021

The company announced mixed Q1 results on a day when many biotech stocks were sinking.

Via The Motley Fool

Agenus Inc (AGEN) Q1 2021 Earnings Call Transcript ↗

May 06, 2021

AGEN earnings call for the period ending April 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.